Marseilles, France

Jean-Michel Brunel

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 1.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jean-Michel Brunel

Introduction

Jean-Michel Brunel is a prominent inventor based in Marseilles, France. He has made significant contributions to the field of antimicrobial agents, holding a total of 8 patents. His work focuses on developing innovative solutions to combat resistant bacteria and infections.

Latest Patents

Among his latest patents are "Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria" and "Amide derivatives of squalamine for the treatment of infections." The first patent addresses the use of Motuporamine agents that exhibit antimicrobial activity. The second patent details a compound designed to treat various infections, including bacterial, fungal, viral, or parasitic infections. This compound is characterized by a specific formula that includes various groups and their stereoisomers, as well as pharmaceutical compositions that incorporate this compound.

Career Highlights

Jean-Michel Brunel has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université d'Aix-Marseille. His career is marked by a commitment to advancing medical research and developing effective treatments for infections.

Collaborations

Some of his notable coworkers include Otto Phanstiel and Jean-Pascal Marc. Their collaborative efforts have contributed to the success of his research and patent developments.

Conclusion

Jean-Michel Brunel's innovative work in the field of antimicrobial agents showcases his dedication to addressing critical health challenges. His patents reflect a significant advancement in the treatment of infections, highlighting the importance of continued research and innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…